ERBB2 and breast cancer: SHP2 overexpression is commonly observed in HER2 (+) ERα⁄PR (+) infiltrating ductal carcinoma, and the elevated level of SHP2 protein in breast cancer is positively correlated with lymph node metastasis and higher tumor grade (23).